Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Organisation › Details

BiovelocITA S.r.l.

BiovelocITA S.r.l. is Italy’s first Italian accelerator dedicated to biotech. It was founded by Sofinnova Partners, a leading European venture capital firm specialized in Life Science which over the past 40 years financed and accompanied almost 500 companies. Through BiovelocITA, entrepreneurs, scientists and investors will collaborate to accelerate world-class biotech projects to preclinical proof of concept. Strived to offer innovative solutions to the medical community and its patients, BiovelocITA will help build market breaking biotech companies in all therapeutic areas. *


  Group Sofinnova (Group)
Products Industry business park management / science park management
  Industry 2 BIOTECH
Persons Person Spinelli, Silvano (BiovelocITA 201511– before EOS SpA 200606– CEO + co-founder + Novupharma)
  Person 2 Camboni, Gabriella (BiovelocITA 201511– before EOS SpA Co-Founder + Novupharma Co-Founder)
Region Region Milano (Milan)
  Country Italy
  City n. a. Milano (MI)
    Address record changed: 2015-12-08
Basic data Employees n. a.
    * Document for �About Section�: Sofinnova Partners. (11/16/15). "Press Release: Sofinnova Launches BiovelocITA – the First Biotech Accelerator in Italy". Milan.
Record changed: 2015-12-08


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Sofinnova (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top